Who Is Excluded: Critical Clarifications This is where patients and prescribers must be particularly careful
Adults seeking the strongest available weight-loss outcome in a brand-name SKU Adults with obesity and moderate-to-severe OSA (cross-listed indication) Adults with pre-diabetes and obesity who want T2D progression prevention Clients who plateaued on a semaglutide SKU and want a tirzepatide trial Clients comfortable with weekly subcutaneous injection In SURMOUNT-5, a 72-week head-to-head trial sponsored by Eli Lilly, adults on Zepbound (tirzepatide) achieved 20.2% mean body weight loss, compared with 13.7% for adults on Wegovy (semaglutide)
Symptoms include persistent fatigue and low energy, brain fog and poor concentration, low mood, anxiety or depression, memory problems, tingling or numbness in hands and feet, poor sleep quality, weakened immune function and hair thinning and loss
Like any medication they can have side effects, which is exactly why our program includes ongoing check-ins and dose adjustments